Inhaled corticosteroid for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Description
CONCLUSIONS: Additional ICS use, particularly inhaled budesonide may help symptom relief in patients with COVID-19. However, ICS use did not help reduce the risk of urgent care, ED visit, hospitalization, or death.
